Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Oct;95(41):e5114.
doi: 10.1097/MD.0000000000005114.

Quality of pharmacoeconomic research in China: A systematic review

Affiliations
Meta-Analysis

Quality of pharmacoeconomic research in China: A systematic review

Huifen Ma et al. Medicine (Baltimore). 2016 Oct.

Abstract

Background: The number of pharmacoeconomic publications in the literature from China has risen rapidly, but the quality of pharmacoeconomic publications from China has not been analyzed.

Objectives: This study aims to identify all recent pharmacoeconomic publications from China, to critically appraise the reporting quality, and to summarize the results.

Methods: Four databases (PubMed, Web of Science, Medline, and EmBase) were searched for original articles published up to December 31, 2014. The Consolidated Health Economic Evaluation Reporting Standards statement including 24 items was used to assess the quality of reporting of these articles.

Results: Of 1046 articles identified, 32 studies fulfilled the inclusion criteria. They were published in 23 different journals. Quality of reporting varied between studies, with an average score of 18.7 (SD = 4.33) out of 24 (range 9-23.5). There was an increasing trend of pharmacoeconomic publications and reporting quality over years from 2003 to 2014. According to the Consolidated Health Economic Evaluation Reporting Standards, the reporting quality for the items including "title," "comparators of method," and "measurement of effectiveness" are quite low, with less than 50% of studies fully satisfying these reporting standards. In contrast, reporting was good for the items including "introduction," "study perspective," "choice of health outcomes," "study parameters," "characterizing heterogeneity," and "discussion," with more than 75% of the articles satisfying these reporting criteria. The remaining items fell in between these 2 extremes, with 50% to 75% of studies satisfying these criteria.

Conclusion: Our study suggests the need for improvement in a number of reporting criteria. But the criteria for which reporting quality was low seem to be limitations that would be straightforward to correct in future studies.

PubMed Disclaimer

Conflict of interest statement

None of the authors have expressed any conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of search results and selection process.
Figure 2
Figure 2
Average score of the publications by year.
Figure 3
Figure 3
Quality of publications per items of the CHEERS checklist. CHEERS = Consolidated Health Economic Evaluation Reporting Standards.

Similar articles

Cited by

References

    1. Mueller C, Schur C, O’Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health 1997; 87:1626–1629. - PMC - PubMed
    1. Brown GC, Brown MM. Value-based medicine and pharmacoeconomics. Dev Ophthalmol 2016; 55:381–390. - PubMed
    1. Rodrigues J, Wu JH, Clay E, et al. Impact of pharmacoeconomics guidelines on the international publications in China. Value Health 2014; 17:A799. - PubMed
    1. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed.New York: Oxford University Press; 2005.
    1. Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health care 2013; 29:117–122. - PubMed

MeSH terms